en 26 Noviembre 2017

Oxidative stress and inflammation play key roles in the pathogenesis of Multiple sclerosis (MS). Different drugs have been used in the clinical practice, however, there is not a completely effective treatment. Due to its potential therapeutic action, medical ozone represents a promising approach for neurodegenerative disorders. The aim of the present study was to address the role of ozone therapy on the cellular redox state in MS patients. Ozone (20μg/ml) was administered three times per week during a month by rectal insufflation. The effect of ozone therapy on biomarkers of oxidative stress and inflammation was addressed by spectrophotometric and immunoenzymatic assays. Furthermore, we investigated the action of ozone on CK2 expression and Nrf2 phosphorylation by western blotting analysis. Medical ozone significantly improved (P < 0.05) the activity of antioxidant enzymes and increased the levels of cellular reduced glutathione. In accordance, a significant reduction (P < 0.05) of oxidative damage on lipids and proteins was observed in ozone-treated patients. As well, the levels of pro-inflammatory cytokines TNFα and IL-1β were lower after ozone treatment. Ozone therapy incremented the CK2 expression together with Nrf2 phosphorylation in mononuclear cells of MS patients. These findings suggest that ozone´s antioxidant and anti-inflammatory effects might be partially associated with an induction of Nrf2 phosphorylation and activation. These results provide new insights on the molecular events modulated by ozone, and pointed out ozone therapy as a potential therapeutic alternative for MS patients. 

en 26 Noviembre 2017

In the last two decades, the use of ozone (O3) as a complementary medical approach has progressively been increasing; however, its application is still limited due to the numerous doubts about its possible toxicity, despite the low concentrations used in therapy. For an appropriate and safe clinical application of a potentially toxic agent such as O3, it is crucial to elucidate the cellular response to its administration. Molecular analyses and transmission electron microscopy were here combined to investigate in vitro the effects of O3administration on transcriptional activity and nuclear domains organization of cultured SH-SY5Y neuronal cells; low O3 concentrations were used as those currently administered in clinical practice. Mild ozonisation did not affect cell proliferation or death, while molecular analyses showed an O3-induced modulation of some genes involved in the cell response to stress (HMOX1, ERCC4, CDKN1A) and in the transcription machinery (CTDSP1). Ultrastructural cytochemistry after experiments of bromouridine incorporation consistently demonstrated an increased transcriptional rate at both the nucleoplasmic (mRNA) and the nucleolar (rRNA) level. No ultrastructural alteration of nuclear domains was observed. Our molecular, ultrastructural and cytochemical data demonstrate that a mild toxic stimulus such as mild ozonisation stimulate cell protective pathways and nuclear transcription, without altering cell viability. This could possibly account for the positive effects observed in ozone-treated patients.

 

 

 

Más información

en 25 Noviembre 2017

Abstrac

The use of ozone (O3) gas as a therapy in alternative medicine has attracted skepticism due to its unstable molecular structure. However, copious volumes of research have provided evidence that O3's dynamic resonance structures facilitate physiological interactions useful in treating a myriad of pathologies. Specifically, O3 therapy induces moderate oxidative stress when interacting with lipids. This interaction increases endogenous production of antioxidants, local perfusion, and oxygen delivery, as well as enhances immune responses. We have conducted a comprehensive review of O3 therapy, investigating its contraindications, routes and concentrations of administration, mechanisms of action, disinfectant properties in various microorganisms, and its medicinal use in different pathologies. We explore the therapeutic value of O3 in pathologies of the cardiovascular system, gastrointestinal tract, genitourinary system, central nervous system, head and neck, musculoskeletal, subcutaneous tissue, and peripheral vascular disease. Despite compelling evidence, further studies are essential to mark it as a viable and quintessential treatment option in medicine.

Leer mas
en 24 Noviembre 2017

Dry eye, an age-related condition, is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance and tear film instability. Environmental factors are also often implicated in dry eye including exposure to pollutants, ultraviolet (UV) radiation and ozone as well as the chronic use of preserved eyedrops such as in the treatment of glaucoma. These factors increase oxidative stress and ocular surface inflammation. Here, we reviewed the cellular, animal and clinical studies that point to the role of oxidative stress in dry eye disease. The biomarkers used to indicate oxidative damage in ocular surface tissues include 8-hydroxy-2 deoxyguanosine (8-OHdG), 4-hydroxynonenal (HNE) and malondialdehyde (MDD). Antioxidative defences in the ocular surface occur in the form of tear proteins such as lactoferrin and S100A proteins, and enzymes such as superoxide dismutase (SOD), peroxidase, catalase and mitochondrial oxidative enzymes. An imbalance between the level of reactive oxygen species (ROS) and the action of protective enzymes will lead to oxidative damage, and possibly inflammation. A small number of interventional studies suggest that oxidative stress may be directly targeted in topical therapy of dry eye treatment. For example, in vitro studies suggest that L-carnitine and pterostilbene, a blueberry component may reduce oxidative stress, and in animal studies, alpha-lipoic acid (ALP) and selenoprotein P may be helpful. Examples of treatments used in clinical trials include vitamin B12 eyedrops and iodide iontophoresis. With recent emphasis on ageing medicine and preventive holistic health, as well as the role of environmental science, research on oxidative stress in the ocular surface is likely to have increasing impact in the coming years.

 

Más Información

en 22 Septiembre 2017

Su autor es el actual Presidente del Comité Científico Internacional de Ozonoterapia (ISCO3 / www.isco3.org), Dr. Gregorio Martínez Sánchez, autor de más de 150 publicaciones sobre Ozonoterapia y activo colaborador de AMOZON.

Leer mas
en 21 Agosto 2017

La Asosiación Mexicana de Ozonoterapia, en coauspicio con la Universidad Autónoma de Sinaloa, a través del Centro de Inventigación y Docencia en Ciencias de la Salud del Hospital Civil de Culiacán (CIDOCS), llevó a cabo el XXVIII PROGRAMA DE ENTRENAMIENTO EN OZONOTERAPIA, (Niveles Básico, Intermedio y Avanzado), en la Ciudad de Culiacán, Sinaloa, del 10 al 15 de Septiembre de 2017.

 

Este curso fue impartido por los prestigiados Doctores:

 

Froylán Alvarado Güémez con el tema: Ozono e Irradiación de sangre Con luz Utravioleta.

- Luisa Batilde Lima Hernández con el tema: Nutrición y Ozonoterapia; Actualidades científicas.

Nora Bazzano Mastelli con el tema: Aplicaciones de Ozonoterapia en Odontología.

Alejandro Zamudio Aguilera con los temas: Uso del Ozono en Patología Discal Degenerativa y Ozonoterapia en el Tratamiento del Pie Diabético Neuroinfeccioso.

Jaime Rebeil Félix con el tema: Técnicas de Inyección con Ozono en Articulaciones Dolorosas.

Lic. Jorge Roberto Caballero Díaz con el tema: Medios y Estrategias legales en el ÁREA MÉDICA sobre los procedimientos de la Ozonoterapia.

 

Contamos con la presencia de representantes médicos de diferentes partes del mundo. Destacaron: Colombia, Perú y Costa Rica. México como usualmente fue el país con mayor asistencia.

 

Dichos asistentes se fueron satisfechos con el aprendizaje adquirido, ya que recibimos muchos comentarios positivos sobre el Curso:

Leer mas